Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders
Shire plc , the global biotechnology leader in rare diseases, today announced the range of real-world and long-term research it will present at the...
Treatment and Management of Rare Lysosomal Diseases highlighted by shire at Global Conference
Shire plc the global biotechnology leader in rare diseases, today announced that it will have 12 presentations, including 11 posters and one oral presentation,...
Positive Results from the Pivotal Phase III ‘OPTIMISMM’ Study of POMALYST/IMNOVID
Celgene Corporation announced that the Phase III, randomized, open-label, international clinical study, OPTIMISMM, achieved its primary endpoint, showing a statistically significant and clinically meaningful...
Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in a phase 1 study evaluating the safety and...
Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant – an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine.
Allergan plc , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two pivotal phase 3 clinical...
Global Women’s Health Divestiture to CVC Capital Partners completed declares Teva
Teva Pharmaceutical Industries Ltd. announced it has completed the sale of a portfolio of products within its global women’s health business across contraception, fertility,...
Guidelines extended to improve the use of feedback from patients in clinical trials.
Researchers recommend changes to international guidelines used in the development of clinical trials in an effort to obtain useful information about the impact of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...